Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Angioplasty, Balloon, Coronary | 23 | 2015 | 1725 | 1.580 |
Why?
|
Myocardial Infarction | 47 | 2021 | 11460 | 1.560 |
Why?
|
Emergency Medical Services | 25 | 2022 | 1923 | 1.490 |
Why?
|
Electrocardiography | 24 | 2021 | 6377 | 1.090 |
Why?
|
Patient Transfer | 9 | 2022 | 794 | 1.000 |
Why?
|
Registries | 34 | 2022 | 8224 | 0.960 |
Why?
|
Out-of-Hospital Cardiac Arrest | 8 | 2021 | 339 | 0.870 |
Why?
|
Myocardial Reperfusion | 9 | 2015 | 338 | 0.850 |
Why?
|
Hospital Mortality | 23 | 2022 | 5294 | 0.840 |
Why?
|
Hypothermia, Induced | 7 | 2021 | 753 | 0.810 |
Why?
|
Cardiology Service, Hospital | 4 | 2018 | 239 | 0.690 |
Why?
|
American Heart Association | 9 | 2022 | 1039 | 0.520 |
Why?
|
Information Services | 1 | 2013 | 236 | 0.390 |
Why?
|
Myocardial Revascularization | 3 | 2014 | 790 | 0.390 |
Why?
|
Graft Occlusion, Vascular | 3 | 2013 | 537 | 0.370 |
Why?
|
Geographic Information Systems | 1 | 2013 | 281 | 0.370 |
Why?
|
Cardiopulmonary Resuscitation | 7 | 2021 | 992 | 0.360 |
Why?
|
Saphenous Vein | 2 | 2010 | 516 | 0.360 |
Why?
|
Bundle-Branch Block | 1 | 2011 | 276 | 0.340 |
Why?
|
After-Hours Care | 3 | 2013 | 102 | 0.340 |
Why?
|
Los Angeles | 9 | 2023 | 243 | 0.330 |
Why?
|
Laboratories | 2 | 2020 | 458 | 0.330 |
Why?
|
Coronary Artery Bypass | 5 | 2010 | 2188 | 0.310 |
Why?
|
Transportation of Patients | 3 | 2014 | 174 | 0.310 |
Why?
|
Coronary Restenosis | 1 | 2010 | 396 | 0.290 |
Why?
|
Drug-Eluting Stents | 2 | 2010 | 681 | 0.290 |
Why?
|
Advance Care Planning | 1 | 2014 | 698 | 0.270 |
Why?
|
Coronary Angiography | 13 | 2019 | 4471 | 0.270 |
Why?
|
Adenosine Monophosphate | 3 | 2013 | 231 | 0.260 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2013 | 577 | 0.260 |
Why?
|
Quality Improvement | 6 | 2019 | 3801 | 0.260 |
Why?
|
Whole Blood Coagulation Time | 1 | 2005 | 30 | 0.250 |
Why?
|
Coronary Disease | 5 | 2013 | 5914 | 0.240 |
Why?
|
Emergency Medical Service Communication Systems | 2 | 2017 | 21 | 0.240 |
Why?
|
Delivery of Health Care, Integrated | 3 | 2018 | 942 | 0.220 |
Why?
|
Heart Arrest | 2 | 2017 | 1514 | 0.210 |
Why?
|
Sirolimus | 1 | 2010 | 1533 | 0.210 |
Why?
|
Paclitaxel | 1 | 2010 | 1732 | 0.210 |
Why?
|
Regional Health Planning | 3 | 2018 | 96 | 0.210 |
Why?
|
Cardiac Output | 1 | 2004 | 831 | 0.200 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 3688 | 0.200 |
Why?
|
Acute Coronary Syndrome | 5 | 2021 | 2190 | 0.200 |
Why?
|
Time Factors | 25 | 2022 | 39967 | 0.200 |
Why?
|
Inpatients | 1 | 2013 | 2548 | 0.190 |
Why?
|
Aged | 48 | 2021 | 169289 | 0.190 |
Why?
|
Middle Aged | 56 | 2022 | 220895 | 0.180 |
Why?
|
Medical Errors | 1 | 2008 | 1263 | 0.180 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 3530 | 0.170 |
Why?
|
Thrombolytic Therapy | 6 | 2008 | 2064 | 0.170 |
Why?
|
Platelet Aggregation Inhibitors | 4 | 2013 | 2751 | 0.170 |
Why?
|
Purinergic P2Y Receptor Antagonists | 2 | 2012 | 284 | 0.170 |
Why?
|
Cardiac Volume | 1 | 2020 | 197 | 0.160 |
Why?
|
Male | 64 | 2022 | 360804 | 0.160 |
Why?
|
Risk Adjustment | 2 | 2016 | 600 | 0.160 |
Why?
|
Quality of Health Care | 2 | 2012 | 4330 | 0.160 |
Why?
|
United States | 32 | 2021 | 72334 | 0.160 |
Why?
|
Ticlopidine | 3 | 2012 | 730 | 0.160 |
Why?
|
Platelet Aggregation | 2 | 2012 | 771 | 0.160 |
Why?
|
Hemorrhage | 5 | 2021 | 3424 | 0.160 |
Why?
|
Humans | 84 | 2023 | 761504 | 0.160 |
Why?
|
Oxygen Consumption | 1 | 2004 | 1866 | 0.150 |
Why?
|
Exercise Test | 2 | 2007 | 2127 | 0.150 |
Why?
|
Female | 63 | 2022 | 392644 | 0.150 |
Why?
|
Regional Medical Programs | 2 | 2009 | 66 | 0.150 |
Why?
|
Immunosuppressive Agents | 1 | 2010 | 4174 | 0.140 |
Why?
|
Referral and Consultation | 1 | 2010 | 3600 | 0.140 |
Why?
|
Survival Rate | 8 | 2019 | 12725 | 0.140 |
Why?
|
Circadian Rhythm | 1 | 2008 | 2576 | 0.140 |
Why?
|
Receptors, Purinergic P2Y12 | 3 | 2012 | 115 | 0.140 |
Why?
|
Clinical Protocols | 2 | 2020 | 1440 | 0.130 |
Why?
|
Atrial Appendage | 1 | 2020 | 283 | 0.130 |
Why?
|
Critical Pathways | 1 | 2020 | 474 | 0.130 |
Why?
|
Health Services Accessibility | 4 | 2016 | 5440 | 0.130 |
Why?
|
Subacute Care | 1 | 2018 | 179 | 0.130 |
Why?
|
Efficiency, Organizational | 2 | 2018 | 695 | 0.130 |
Why?
|
Retrospective Studies | 22 | 2023 | 80636 | 0.120 |
Why?
|
Sex Characteristics | 2 | 2021 | 2639 | 0.120 |
Why?
|
Quality Indicators, Health Care | 2 | 2018 | 1792 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 6 | 2020 | 20570 | 0.110 |
Why?
|
Cardiac Care Facilities | 1 | 2014 | 34 | 0.110 |
Why?
|
Telemetry | 1 | 2015 | 199 | 0.110 |
Why?
|
Heparin | 3 | 2013 | 1634 | 0.110 |
Why?
|
Cyclic N-Oxides | 1 | 2013 | 72 | 0.110 |
Why?
|
Heart Diseases | 2 | 2020 | 2781 | 0.110 |
Why?
|
Creatine Kinase, MB Form | 2 | 2011 | 202 | 0.110 |
Why?
|
Calcinosis | 1 | 2002 | 1469 | 0.110 |
Why?
|
Selection Bias | 2 | 2007 | 359 | 0.110 |
Why?
|
Thrombosis | 4 | 2020 | 2942 | 0.110 |
Why?
|
California | 3 | 2015 | 1429 | 0.110 |
Why?
|
Clinical Competence | 1 | 2008 | 4792 | 0.110 |
Why?
|
Coronary Artery Disease | 5 | 2012 | 6403 | 0.100 |
Why?
|
Observation | 2 | 2012 | 310 | 0.100 |
Why?
|
Models, Theoretical | 1 | 2004 | 3575 | 0.100 |
Why?
|
Aged, 80 and over | 17 | 2020 | 58976 | 0.100 |
Why?
|
Stents | 4 | 2013 | 3179 | 0.100 |
Why?
|
False Positive Reactions | 2 | 2020 | 957 | 0.100 |
Why?
|
Heart Septal Defects, Atrial | 2 | 2005 | 451 | 0.100 |
Why?
|
Treatment Outcome | 19 | 2023 | 64680 | 0.100 |
Why?
|
Fibrinolytic Agents | 3 | 2015 | 2084 | 0.100 |
Why?
|
Resuscitation | 1 | 2016 | 673 | 0.090 |
Why?
|
Electric Countershock | 1 | 2014 | 533 | 0.090 |
Why?
|
Risk Factors | 15 | 2021 | 74206 | 0.090 |
Why?
|
Patient Discharge | 2 | 2018 | 3443 | 0.090 |
Why?
|
Survival Analysis | 6 | 2019 | 10090 | 0.090 |
Why?
|
Hospitals | 5 | 2017 | 3882 | 0.090 |
Why?
|
Quinazolinones | 1 | 2012 | 221 | 0.090 |
Why?
|
Hotlines | 1 | 2010 | 55 | 0.090 |
Why?
|
Troponin | 2 | 2011 | 502 | 0.090 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2010 | 146 | 0.090 |
Why?
|
Myocardial Ischemia | 2 | 2013 | 2113 | 0.090 |
Why?
|
Risk Assessment | 7 | 2015 | 23995 | 0.080 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1265 | 0.080 |
Why?
|
Chi-Square Distribution | 3 | 2010 | 3416 | 0.080 |
Why?
|
Time and Motion Studies | 2 | 2008 | 143 | 0.080 |
Why?
|
Total Quality Management | 1 | 2010 | 265 | 0.080 |
Why?
|
Anticoagulants | 3 | 2013 | 4812 | 0.080 |
Why?
|
Program Evaluation | 4 | 2020 | 2495 | 0.080 |
Why?
|
Heart Failure | 1 | 2013 | 11669 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2011 | 3245 | 0.080 |
Why?
|
Incidence | 6 | 2020 | 21353 | 0.080 |
Why?
|
Decision Support Techniques | 1 | 2018 | 1998 | 0.080 |
Why?
|
Comorbidity | 3 | 2012 | 10508 | 0.080 |
Why?
|
Cholesterol, HDL | 1 | 2014 | 1814 | 0.080 |
Why?
|
Emergency Service, Hospital | 3 | 2014 | 7879 | 0.080 |
Why?
|
Choice Behavior | 2 | 2015 | 824 | 0.080 |
Why?
|
Cause of Death | 3 | 2013 | 3683 | 0.070 |
Why?
|
Guideline Adherence | 4 | 2019 | 2220 | 0.070 |
Why?
|
Exercise | 1 | 2004 | 5890 | 0.070 |
Why?
|
Multivariate Analysis | 5 | 2016 | 12059 | 0.070 |
Why?
|
Receptors, Purinergic P2 | 1 | 2008 | 150 | 0.070 |
Why?
|
Internal Mammary-Coronary Artery Anastomosis | 1 | 2007 | 38 | 0.070 |
Why?
|
Program Development | 2 | 2020 | 1297 | 0.070 |
Why?
|
Comparative Effectiveness Research | 1 | 2012 | 709 | 0.070 |
Why?
|
Mammary Arteries | 1 | 2007 | 81 | 0.070 |
Why?
|
Tissue Plasminogen Activator | 1 | 2012 | 1164 | 0.070 |
Why?
|
History, 21st Century | 1 | 2012 | 1567 | 0.070 |
Why?
|
Cardiovascular System | 1 | 2013 | 834 | 0.070 |
Why?
|
Practice Guidelines as Topic | 5 | 2021 | 7390 | 0.070 |
Why?
|
Patient Admission | 2 | 2020 | 1367 | 0.060 |
Why?
|
Odds Ratio | 7 | 2016 | 9646 | 0.060 |
Why?
|
Cholesterol, LDL | 1 | 2014 | 2382 | 0.060 |
Why?
|
Platelet Activation | 1 | 2008 | 645 | 0.060 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2008 | 495 | 0.060 |
Why?
|
Length of Stay | 1 | 2018 | 6425 | 0.060 |
Why?
|
Sex Factors | 5 | 2016 | 10552 | 0.060 |
Why?
|
History, 20th Century | 1 | 2012 | 2767 | 0.060 |
Why?
|
Chemokines | 1 | 2008 | 960 | 0.060 |
Why?
|
Intraoperative Period | 1 | 2005 | 510 | 0.060 |
Why?
|
Hypolipidemic Agents | 1 | 2008 | 609 | 0.060 |
Why?
|
Coronary Thrombosis | 1 | 2007 | 440 | 0.060 |
Why?
|
Prognosis | 6 | 2017 | 29625 | 0.060 |
Why?
|
Emergencies | 1 | 2010 | 1217 | 0.060 |
Why?
|
Hospitalization | 4 | 2017 | 10723 | 0.060 |
Why?
|
Hormone Replacement Therapy | 2 | 2013 | 751 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5336 | 0.050 |
Why?
|
Peptides | 2 | 2013 | 4358 | 0.050 |
Why?
|
Nervous System Diseases | 1 | 2014 | 1666 | 0.050 |
Why?
|
Proportional Hazards Models | 4 | 2012 | 12463 | 0.050 |
Why?
|
Health Care Surveys | 1 | 2010 | 2426 | 0.050 |
Why?
|
Data Collection | 1 | 2012 | 3322 | 0.050 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2011 | 1723 | 0.050 |
Why?
|
Testosterone | 1 | 2013 | 2472 | 0.050 |
Why?
|
Workload | 1 | 2008 | 844 | 0.050 |
Why?
|
Medroxyprogesterone Acetate | 1 | 2003 | 155 | 0.050 |
Why?
|
Sulfonamides | 1 | 2012 | 1978 | 0.050 |
Why?
|
Prospective Studies | 9 | 2020 | 54425 | 0.050 |
Why?
|
Pyridines | 1 | 2013 | 2875 | 0.050 |
Why?
|
Fatigue | 1 | 2008 | 1552 | 0.050 |
Why?
|
Follow-Up Studies | 8 | 2019 | 39106 | 0.050 |
Why?
|
Organizational Objectives | 2 | 2016 | 426 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2021 | 4016 | 0.050 |
Why?
|
Comprehensive Health Care | 1 | 2021 | 123 | 0.050 |
Why?
|
Injections, Intravenous | 2 | 2013 | 1379 | 0.040 |
Why?
|
Bystander Effect | 1 | 2020 | 90 | 0.040 |
Why?
|
Models, Organizational | 2 | 2018 | 546 | 0.040 |
Why?
|
Double-Blind Method | 5 | 2013 | 12341 | 0.040 |
Why?
|
Age Factors | 4 | 2011 | 18395 | 0.040 |
Why?
|
Staphylococcal Infections | 1 | 2008 | 1408 | 0.040 |
Why?
|
Health Education | 2 | 2021 | 1052 | 0.040 |
Why?
|
Health Maintenance Organizations | 1 | 2002 | 659 | 0.040 |
Why?
|
Drug Monitoring | 1 | 2005 | 962 | 0.040 |
Why?
|
Recurrence | 2 | 2008 | 8465 | 0.040 |
Why?
|
Hemoglobins | 1 | 2004 | 1525 | 0.040 |
Why?
|
Point-of-Care Systems | 1 | 2007 | 1213 | 0.040 |
Why?
|
Angina Pectoris | 1 | 2002 | 959 | 0.040 |
Why?
|
Premenopause | 1 | 2002 | 1039 | 0.040 |
Why?
|
Ultrasonography, Interventional | 1 | 2006 | 1496 | 0.040 |
Why?
|
Stroke Volume | 1 | 2011 | 5496 | 0.040 |
Why?
|
Blood Platelets | 1 | 2008 | 2479 | 0.040 |
Why?
|
Cross-Sectional Studies | 4 | 2022 | 26125 | 0.040 |
Why?
|
Peptide Fragments | 2 | 2007 | 5112 | 0.040 |
Why?
|
Logistic Models | 4 | 2014 | 13255 | 0.030 |
Why?
|
Infusions, Intravenous | 2 | 2013 | 2219 | 0.030 |
Why?
|
Postmenopause | 2 | 2003 | 2513 | 0.030 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2010 | 2243 | 0.030 |
Why?
|
Treatment Failure | 3 | 2009 | 2645 | 0.030 |
Why?
|
Estradiol | 1 | 2003 | 1937 | 0.030 |
Why?
|
Algorithms | 4 | 2020 | 14031 | 0.030 |
Why?
|
Hirudins | 2 | 2007 | 179 | 0.030 |
Why?
|
Minnesota | 1 | 2016 | 338 | 0.030 |
Why?
|
Cohort Studies | 5 | 2015 | 41487 | 0.030 |
Why?
|
Organizational Case Studies | 1 | 2016 | 301 | 0.030 |
Why?
|
Cardiovascular Diseases | 2 | 2013 | 15500 | 0.030 |
Why?
|
Acute-Phase Reaction | 1 | 2014 | 91 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2008 | 3889 | 0.030 |
Why?
|
Drug Delivery Systems | 1 | 2006 | 2226 | 0.030 |
Why?
|
Dyslipidemias | 2 | 2012 | 868 | 0.030 |
Why?
|
Policy Making | 1 | 2018 | 542 | 0.030 |
Why?
|
ROC Curve | 1 | 2002 | 3579 | 0.030 |
Why?
|
Heart Atria | 1 | 2020 | 1345 | 0.030 |
Why?
|
Adult | 8 | 2023 | 221177 | 0.030 |
Why?
|
Administration, Oral | 2 | 2012 | 4021 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2020 | 15266 | 0.030 |
Why?
|
Drug Antagonism | 1 | 2012 | 51 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18252 | 0.030 |
Why?
|
Databases, Factual | 3 | 2016 | 7967 | 0.030 |
Why?
|
Drug Utilization | 2 | 2008 | 1188 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2010 | 20098 | 0.020 |
Why?
|
Needs Assessment | 1 | 2017 | 1139 | 0.020 |
Why?
|
Disease-Free Survival | 2 | 2012 | 6814 | 0.020 |
Why?
|
Disease Management | 1 | 2021 | 2508 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 2 | 2012 | 6484 | 0.020 |
Why?
|
Platelet Function Tests | 1 | 2012 | 271 | 0.020 |
Why?
|
Cardiac Surgical Procedures | 1 | 2005 | 3627 | 0.020 |
Why?
|
Insurance, Health | 1 | 2002 | 2498 | 0.020 |
Why?
|
Severity of Illness Index | 3 | 2013 | 15842 | 0.020 |
Why?
|
Health Policy | 1 | 2021 | 2684 | 0.020 |
Why?
|
Receptors, Purinergic P2X | 1 | 2008 | 9 | 0.020 |
Why?
|
Physicians | 1 | 2007 | 4591 | 0.020 |
Why?
|
Health Planning Councils | 1 | 2008 | 11 | 0.020 |
Why?
|
Echocardiography, Transesophageal | 2 | 2005 | 1086 | 0.020 |
Why?
|
Ambulances | 1 | 2009 | 91 | 0.020 |
Why?
|
Urban Population | 1 | 2016 | 2036 | 0.020 |
Why?
|
Medicaid | 1 | 2002 | 2818 | 0.020 |
Why?
|
Health Services Research | 1 | 2016 | 1812 | 0.020 |
Why?
|
Retreatment | 1 | 2009 | 598 | 0.020 |
Why?
|
Risk | 2 | 2013 | 9610 | 0.020 |
Why?
|
Healthcare Disparities | 2 | 2016 | 3358 | 0.020 |
Why?
|
Triglycerides | 1 | 2014 | 2461 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2002 | 14666 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2007 | 6534 | 0.020 |
Why?
|
Canada | 1 | 2012 | 2122 | 0.020 |
Why?
|
Chronology as Topic | 1 | 2005 | 5 | 0.020 |
Why?
|
Antithrombin III | 1 | 2006 | 128 | 0.020 |
Why?
|
Prothrombin | 1 | 2006 | 191 | 0.020 |
Why?
|
Animals | 3 | 2013 | 168459 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2012 | 1787 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2016 | 2169 | 0.020 |
Why?
|
Chemokine CCL5 | 1 | 2006 | 214 | 0.020 |
Why?
|
Europe | 1 | 2012 | 3422 | 0.020 |
Why?
|
Coronary Vessels | 2 | 2007 | 3096 | 0.020 |
Why?
|
Smoking | 2 | 2012 | 9053 | 0.020 |
Why?
|
Primary Health Care | 1 | 2021 | 4686 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2008 | 1541 | 0.010 |
Why?
|
Health Status Disparities | 1 | 2016 | 1852 | 0.010 |
Why?
|
Creatinine | 1 | 2010 | 1899 | 0.010 |
Why?
|
Balloon Occlusion | 1 | 2005 | 125 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2007 | 15631 | 0.010 |
Why?
|
CD40 Ligand | 1 | 2006 | 522 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2012 | 4853 | 0.010 |
Why?
|
Vascular Patency | 1 | 2007 | 911 | 0.010 |
Why?
|
Utilization Review | 1 | 2005 | 382 | 0.010 |
Why?
|
Medicare | 1 | 2002 | 6770 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8654 | 0.010 |
Why?
|
Diabetes Mellitus | 2 | 2012 | 5840 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2010 | 2115 | 0.010 |
Why?
|
Preoperative Care | 1 | 2012 | 2242 | 0.010 |
Why?
|
Blood Flow Velocity | 1 | 2007 | 1371 | 0.010 |
Why?
|
Surgery Department, Hospital | 1 | 2004 | 176 | 0.010 |
Why?
|
Rabbits | 1 | 2008 | 4772 | 0.010 |
Why?
|
Community Health Services | 1 | 2007 | 656 | 0.010 |
Why?
|
Triage | 1 | 2009 | 986 | 0.010 |
Why?
|
Hypertension | 2 | 2012 | 8540 | 0.010 |
Why?
|
Atrial Fibrillation | 1 | 2020 | 5127 | 0.010 |
Why?
|
Health Services Needs and Demand | 1 | 2008 | 1403 | 0.010 |
Why?
|
Emergency Treatment | 1 | 2004 | 496 | 0.010 |
Why?
|
Staphylococcus aureus | 1 | 2008 | 1458 | 0.010 |
Why?
|
Withholding Treatment | 1 | 2004 | 617 | 0.010 |
Why?
|
Morbidity | 1 | 2005 | 1750 | 0.010 |
Why?
|
Angiography | 1 | 2005 | 1595 | 0.010 |
Why?
|
Benchmarking | 1 | 2005 | 1045 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2009 | 8529 | 0.010 |
Why?
|
Adolescent | 1 | 2005 | 88319 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2013 | 10209 | 0.010 |
Why?
|
Acute Disease | 1 | 2007 | 7237 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2006 | 3208 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2006 | 3826 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2003 | 6310 | 0.010 |
Why?
|
Patient Compliance | 1 | 2003 | 2690 | 0.010 |
Why?
|
Critical Illness | 1 | 2006 | 2723 | 0.010 |
Why?
|
Contrast Media | 1 | 2006 | 5311 | 0.010 |
Why?
|
Echocardiography | 1 | 2005 | 4989 | 0.010 |
Why?
|
Obesity | 1 | 2012 | 12947 | 0.010 |
Why?
|
Stroke | 1 | 2012 | 9757 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 17904 | 0.010 |
Why?
|
Patient Selection | 1 | 2002 | 4244 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2006 | 9000 | 0.010 |
Why?
|
Disease Progression | 1 | 2003 | 13506 | 0.000 |
Why?
|